We were the first to report that N 3 -phenacyluridine (1h) (0.5 mmol/mouse) injected by i.c.v. exhibited antinociceptive effect by the tail pinch, hot plate and acetic-acid induced abdominal constriction method. 1) In connection with this finding, uridine is known to possess central nervous system (CNS) depressant effects such as anticonvulsant activity and decreasing spontaneous activities in mice.2,3) CNS depressant effects of uridine were partly explained through the action on the GABA receptor.4) In addition, uridine was reported to have the natural sleep-promoting effect by intracerebral infusion to rats, 5) and the potent sedative-hypnotic activity of N 3 -substituted uridine was also revealed in mice.6) Further studies have been conducted using thymidine, 2Ј-deoxyuridine, 6-azauridine, 2Ј,3Ј-O-isopropylideneuridine as lead compounds. The results indicated that 1h was the most potent hypnotic compound among derivatives tested. [7][8][9][10][11][12][13][14][15][16] Those N 3 -substituted pyrimidine nucleosides also possess certain pharmacological effects i.e., barbiturate-and/or benzodiazepineinduced sleep prolonging effects, motor incoordination, decreasing spontaneous activity, and so on. However, the antinociceptive effects of pyrimidine nucleosides and their derivatives have not been well investigated. Since 1h has the antinociceptive property, we, therefore, synthesized series of the derivatives of N 3 -phenacyl pyrimidine nucleosides in order to find more potent antinociceptive compounds than 1h.The present study evaluated the antinociceptive effects of N 3 -substituted derivatives synthesized from 6 kinds of pyrimidine nucleosides in mice.
ChemistryThe structural modification was mainly carried out at the N 3 -position of the pyrimidine ring. Seventy eight of N 3 -substituted pyrimidine nucleosides, methyl (1-6 a), ethyl (1-6 b), allyl (1-6 c), benzyl (1-6 d), xylyl (methylbenzyl) (1-6 e, f, g), phenacyl (1-6 h), methoxyphenacyl (1-6 i, j, k) and dimethoxyphenacyl derivatives (1-6 l, m), were synthesized from uridine (1), thymidine (2), 2Ј-deoxyuridine (3), 6-azauridine (4), 2Ј,3Ј-O-isopropylideneuridine (5), and arabinofuranosyluracil (6) as lead compounds according to the method of reported previously.
6-17)
Results and DiscussionThe antinociceptive effects of uridine (1) and its derivatives at the dose of 0.5 mmol/mouse by i.c.v. injection are summarized in Table 1. Uridine (1), the alkyl and allyl compounds 1a-c were inactive or only slightly active by the hot plate test, whereas benzyl and phenacyl substituted uridines (1d, h) possessed 22 and 16% of the activities, respectively. The results supported that 1h possessed the antinociception in mice reported previously.1) The other analogues, N 3 -o-, m-, and p-xylyl-(1e-g), and N
-o, m, and p-methoxyphenacyl